Citadel Advisors
AGN

Citadel Advisors’s Allergan plc AGN Stock Holding History

Citadel Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-68,900
Closed -$12.2M – 10922
2020
Q1 		$12.2M Sell
68,900
-212,100
-75% -$39.9M 0.01% 1661
2019
Q4 		$53.7M Buy
281,000
+86,600
+45% +$15.6M 0.02% 731
2019
Q3 		$32.7M Sell
194,400
-137,700
-41% -$22.4M 0.02% 1054
2019
Q2 		$55.6M Sell
332,100
-12,700
-4% -$1.76M 0.03% 671
2019
Q1 		$50.5M Sell
344,800
-129,100
-27% -$18.7M 0.03% 688
2018
Q4 		$63.3M Sell
473,900
-68,900
-13% -$11.3M 0.03% 504
2018
Q3 		$103M Sell
542,800
-231,000
-30% -$42.4M 0.05% 403
2018
Q2 		$129M Sell
773,800
-195,000
-20% -$31.3M 0.06% 280
2018
Q1 		$163M Buy
968,800
+50,400
+5% +$8.45M 0.09% 170
2017
Q4 		$150M Buy
918,400
+259,900
+39% +$46.6M 0.09% 200
2017
Q3 		$135M Buy
658,500
+77,600
+13% +$18M 0.1% 165
2017
Q2 		$141M Buy
580,900
+18,700
+3% +$4.39M 0.12% 141
2017
Q1 		$134M Sell
562,200
-190,700
-25% -$44.4M 0.12% 135
2016
Q4 		$158M Buy
752,900
+191,300
+34% +$39.6M 0.16% 91
2016
Q3 		$129M Buy
561,600
+28,600
+5% +$6.99M 0.13% 107
2016
Q2 		$123M Buy
533,000
+190,400
+56% +$43.9M 0.14% 107
2016
Q1 		$91.8M Buy
342,600
+63,700
+23% +$18.2M 0.12% 141
2015
Q4 		$87.2M Sell
278,900
-1,400
-0.5% -$417K 0.1% 217
2015
Q3 		$76.2M Buy
280,300
+65,300
+30% +$20.1M 0.07% 270
2015
Q2 		$65.2M Sell
215,000
-38,700
-15% -$11.5M 0.06% 384
2015
Q1 		$75.5M Buy
253,700
+110,900
+78% +$31.6M 0.07% 314
2014
Q4 		$36.8M Sell
142,800
-38,100
-21% -$9.52M 0.04% 624
2014
Q3 		$43.6M Buy
180,900
+71,400
+65% +$16M 0.05% 480
2014
Q2 		$24.4M Sell
109,500
-28,600
-21% -$5.92M 0.03% 700
2014
Q1 		$28.4M Buy
138,100
+39,000
+39% +$7.73M 0.03% 627
2013
Q4 		$16.6M Buy
99,100
+12,100
+14% +$1.89M 0.02% 912
2013
Q3 		$12.5M Buy
87,000
+33,800
+64% +$4.5M 0.02% 974
2013
Q2 		$6.71M Buy
+53,200
New +$6.02M 0.01% 1320

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Citadel Advisors's AGN Position: Q2 2020 in Review

Citadel Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,402,442 shares — an estimated $603M sold.

Citadel Advisors first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $603M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Citadel Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Citadel Advisors sold 3,402,442 Allergan plc shares in Q2 2020, an estimated $603M.
  • Citadel Advisors first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Citadel Advisors's Allergan plc position peaked at $603M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.